Ethris funding News – Germany-based Ethris Announces $5 Mn Funding
Jun 19, 2024 | By Team SR
![Ethris GmbH, a leading biotechnology company pioneering next-generation RNA therapeutics and vaccines, announced that it has received funding from the Gates Foundation to support the advancement of the company’s lead mRNA-based product candidate, ETH47.](https://startuprise.co.uk/wp-content/uploads/2024/06/Ethris.webp)
Ethris GmbH, a leading biotechnology company pioneering next-generation RNA therapeutics and vaccines, announced that it has received funding from the Gates Foundation to support the advancement of the company’s lead mRNA-based product candidate, ETH47.
This funding of $5 million includes an equity investment component expected to close at the company’s next financing round. The new capital will enable the company to rapidly reach Phase 2 readiness and build out the CMC manufacturing process for the next clinical trial.
Read also - FINBOURNE funding news – London-based FINBOURNE Technology Secures £55 Million in Series B Round Funding
RECOMMENDED FOR YOU
![recomd](https://startuprise.co.uk/wp-content/uploads/2024/06/Zurich-based-Rivia-Secures-E3-Million-in-Seed-Funding.webp)
Rivia funding news – Zurich-based Rivia Secures €3 Million in Seed Funding
Startup Rise EU
Jun 12, 2024
![recomd](https://startuprise.co.uk/wp-content/uploads/2023/11/Copenhagen-based-Virtuall-Secures-E829k-in-Pre-Seed-Funding.webp)
[Funding alert] Copenhagen-based Virtuall Secures €829k in Pre-Seed Funding
Startup Rise EU
Nov 9, 2023
![recomd](https://startuprise.co.uk/wp-content/uploads/2024/02/Cambridge-based-Startup-Zetta-Genomics-Raises-Additional-1.8-Million-in-Seed-Funding.webp)
[Funding alert] Cambridge-based Startup, Zetta Genomics Raises Additional £1.8 Million in Seed Funding
Startup Rise EU
Feb 9, 2024
“Ethris’ lead mRNA-based product candidate ETH47 was designed to have broad antiviral capabilities, placing it in a distinct position to address a range of virus-induced respiratory infections and chronic respiratory diseases. Ethris, supported by the new funding from the Gates Foundation, will accelerate its clinical development, initially targeting asthma exacerbations, an indication with a high unmet medical need where approximately 80% of acute asthma attacks are associated with virus infections. We are grateful for the foundation's support in our mission to combat the global burden of current and emerging respiratory infections by harnessing the full scope of ETH47's virus-agnostic potential,” said Dr. Carsten Rudolph, CEO of Ethris.
A Phase 1 study is ongoing with Ethris’ inhaled mRNA candidate ETH47 to evaluate safety, tolerability, and target engagement in healthy participants. A full data readout is planned for the third quarter of 2024. The ETH47 program is also supported by the BayTherapie2020 program, an initiative of the German state of Bavaria
About Ethris
Ethris, a clinical stage biotech company, has paved a new path from genes to therapeutic proteins, using its proprietary RNA and lipidoid nanoparticle technology platform to discover, design and develop innovative therapies. With more than a decade as an mRNA pioneer, Ethris is a global leader in delivering stabilized mRNAs directly to the respiratory system via optimised formulation and nebulisation technologies.
The company is rapidly advancing its mRNA pipeline of immuno-modulation, protein replacement therapies, and differentiated vaccines, with the ultimate goal of improving patients’ lives.
Recommended Stories for You
![story](https://startuprise.co.uk/wp-content/uploads/2024/05/E-commerce-pre-order-and-waitlist-platform-Purple-Dot-Secures-E9.2-Million-in-Series-A-Round-Funding.webp)
Purple Dot funding news – E-commerce Pre-Order and Waitlist Platform Purple Dot Secures €9.2 Million in Series A Round Funding
Startup Rise EU May 15, 2024
![story](https://startuprise.co.uk/wp-content/uploads/2024/05/UK-based-Whitman-Controls-Secures-4.5Million-in-Funding.webp)
Whitman Controls funding news – Whitman Controls Secures $4.5Million in Funding
Startup Rise EU May 2, 2024
![story](https://startuprise.co.uk/wp-content/uploads/2024/04/Manchester-based-Lemon-secures-over-E580K-in-Pre-Seed-Funding.webp)
[Funding alert] Manchester-based Lemon secures over €580K in Pre-Seed Funding
Startup Rise EU Apr 18, 2024
![story](https://startuprise.co.uk/wp-content/uploads/2024/01/Spanish-Mobility-Company-Cabify-was-Secures-E15-Million-loan-from-BBVA-Spark-.webp)
[Funding alert] Spanish Mobility Company Cabify was Secures €15 Million loan from BBVA Spark
Startup Rise EU Jan 11, 2024
![story](https://startuprise.co.uk/wp-content/uploads/2023/12/Berlin-based-ecoworks-Secures-E40-Million-in-Funding.webp)
[Funding alert] Berlin-based ecoworks Secures €40 Million in Funding
Startup Rise EU Dec 14, 2023
![story](https://startuprise.co.uk/wp-content/uploads/2024/06/Berlin-based-recap-Secures-E13.5-Million-in-Series-A-Round-Funding.webp)
re:cap funding news – Berlin-based re:cap Secures $14.6 Million in Series A Round Funding
Startup Rise EU Jun 4, 2024